EUVIMEDEUVIMED entdecken
Crossref

Cannabidiol in Drug-Resistant Epilepsy (DRE) in Children: A Retrospective Study

Vykuntaraju K Gowda iD, Halima Simin, Uddhava V Kinhal, G V Basavaraja, K S Sanjay

Indian Pediatrics · 2025

DOI: 10.1007/s13312-025-00075-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Pediatrics, 2025. Verfasst von Vykuntaraju K Gowda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Neurology, Indira Gandhi Institute of Child Health, Bangalore, Karnataka, 560029, India. drknvraju08@gmail.com. Hauptthemen laut MEDLINE: Cannabidiol, Drug Resistant Epilepsy, Anticonvulsants. Die Arbeit nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To describe the effectiveness and tolerability of cannabidiol (CBD) in children with drug-resistant epilepsy (DRE). METHODS: Records of children with DRE who received CBD for at least six months were reviewed. Reduction in seizure frequency [complete (> 90%), partial (30-90%), no response (< 30%)], parent reported adverse effects and discontinuation of CBD, if any, were noted. RESULTS: Records of 50 children with DRE (Lennox-Gastaut syndrome 32, Dravet syndrome 4, and Tuberous sclerosis complex 2), mean (SD) age 7.8 (4.3) years were reviewed. Complete, partial, and no response to CBD was seen in 10, 18 and 14 children; 8 became seizure-free. Eight children discontinued treatment due to lack of efficacy (n = 4), by increased adverse effects (n = 3) and aggravation of seizures (n = 1). Adverse effects were noted in 22 (44%), none required hospitalization. CONCLUSION: Cannabidiol is a useful and safe add-on drug in children with DRE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolDrug Resistant EpilepsyAnticonvulsantsHumansChildRetrospective StudiesMaleFemaleChild, PreschoolAdolescentTreatment OutcomeInfant

Stichwörter der Autor:innen

Dravet syndromeLennox–Gastaut syndromeRefractory epilepsyTuberous sclerosis complex

Substanzen

CannabidiolAnticonvulsants

Autor:innen und Institutionen

  • Department of Pediatric Neurology, Indira Gandhi Institute of Child Health, Bangalore, Karnataka, 560029, India. drknvraju08@gmail.com.
  • Department of Pediatrics, Indira Gandhi Institute of Child Health, Bangalore, Karnataka, India.
  • Department of Pediatric Neurology, Indira Gandhi Institute of Child Health, Bangalore, Karnataka, 560029, India.

ORCID-Profile: Vykuntaraju K Gowda

Zitieren

APA

Gowda, V. K., Simin, H., Kinhal, U. V., Basavaraja, G. V., & Sanjay, K. S. (2025). Cannabidiol in Drug-Resistant Epilepsy (DRE) in Children: A Retrospective Study. Indian Pediatrics. https://doi.org/10.1007/s13312-025-00075-9

Vancouver

Gowda VK, Simin H, Kinhal UV, Basavaraja GV, Sanjay KS. Cannabidiol in Drug-Resistant Epilepsy (DRE) in Children: A Retrospective Study. Indian Pediatrics. 2025. doi:10.1007/s13312-025-00075-9

BibTeX
@article{Gowda2025,
  author = {Gowda, Vykuntaraju K and Simin, Halima and Kinhal, Uddhava V and Basavaraja, G V and Sanjay, K S},
  title = {Cannabidiol in Drug-Resistant Epilepsy (DRE) in Children: A Retrospective Study},
  journal = {Indian Pediatrics},
  year = {2025},
  doi = {10.1007/s13312-025-00075-9}
}
Kostenlos starten →